Life Sciences

The mission of HS Life Sciences is to provide a forum to review and discuss what is now possible in the industry.

Welcome to HS Life Sciences
Menu Links
Path
contact-us
Link text
Contact Us
Path
about-us
Link text
About Us
Path
courses
Link text
Events
Footer Banner
Footer Contact Us

CONTACT US
Ruskin House, 40-41 Museum Street, London WC1A 1LT, UK

Footer Copyright Notice

Henry Stewart Conference Studies LLP is a limited liability partnership, registered in England, registration number OC334769 with its registered office at 40-41 Museum Street, London WC1A 1LT. Henry Stewart Events Ltd is a limited company, registered in England, registration number 06532399 with its registered office at 40-41 Museum Street, London WC1A 1LT. Henry Stewart Events, Inc. is a corporation incorporated in the State of Delaware, USA having a business office at PKF O’Connor Davies LLP, 665 Fifth Avenue, New York NY 10022.
© Henry Stewart Conference Studies LLP or its affiliates.

Display Name
HS Life Sciences
Banner Image

Life Sciences Speaker Professor Marc Pallardy

Marc Pallardy, Pharm D 1982, PhD in Toxicology 1987, Full professor and Head of the Department of Toxicology (Faculty of Pharmacy, University of Paris-Saclay) since 1997.  Marc is currently Dean of the Faculty of Pharmacy, University Paris-Saclay (since 2015) and Head of the Team 2 “Drug and Chemical Allergy, Immunotoxicology and Immunopathology”, INSERM UMR 996.

Life Sciences Speaker Claire Bonal

After completing her MD PhD at the University of Geneva Medical School, Claire did a postdoctoral fellowship at Harvard University studying key regulators of pancreatic beta cell development and regeneration. In 2010, Claire transitioned to industry joining Merrimack Pharmaceuticals in Cambridge, MA to advance their anti-EGFR program in oncology. In 2013, Claire joined Novartis leading the cross-functional team for Switzerland developing strategic imperatives in development, medical affairs, market access and commercial strategy with a focus on orphan drugs in rare diseases.

Events Translational Medicine and the Physician Scientist Video 2

View: Translational Medicine at Novartis Institutes for BioMedical Research (NIBR)

In this video series, Novartis Institutes for Biomedical Research (NIBR) explains their approach for early drug development, called ‘Translational Medicine’. This includes an introduction into the role of Translational Medicine, as well as corresponding videos for the offered webinars.

 

The Role of Translational Medicine at Novartis Institutes for BioMedical Research (NIBR)

 

Life Sciences Hub Speaker Dr Aoife Brennan

Dr. Aoife Brennan is an experienced physician scientist and drug developer responsible for the successful clinical development and registration of multiple transformative medicines. Aoife has served as Synlogic’s president and chief executive officer since May 2018.

Life Sciences Speaker Dr Aoife Brennan

Dr. Aoife Brennan is an experienced physician scientist and drug developer responsible for the successful clinical development and registration of multiple transformative medicines. Aoife has served as Synlogic’s president and chief executive officer since May 2018.

Life Sciences HS Talks

Translational Medicine in HSTalks’ The Biomedical & Life Sciences Collection

The Biomedical & Life Sciences Collection contains over 3,000 specially commissioned, seminar-style talks and interviews by leading world experts, including Nobel Laureates and Lasker prize winners. Topics range from basic science to therapeutic intervention, from single molecules to entire populations, relevant to drug discovery, pre-clinical research and development, clinical trials, medical and regulatory affairs and more. 

Life Sciences Hub Speaker Garret FitzGerald

Dr. Garret FitzGerald is the McNeil Professor in Translational Medicine and Therapeutics at the University of Pennsylvania in Philadelphia, where he directs the Institute for Translational Medicine and Therapeutics.

Life Sciences